Performance Forecast - The company expects a positive net profit for the period from January 1, 2025, to June 30, 2025, with an estimated net profit range of 26.49 million to 32.25 million yuan, representing a year-on-year increase [1] - Projected operating revenue is 394.63 million yuan, reflecting a growth of 5% to 15% compared to the same period last year [1] - The net profit attributable to shareholders is expected to be between 20.21 million and 22.66 million yuan, with a significant increase of 230% to 270% in net profit after deducting non-recurring gains and losses [1] Financial Adjustments - The company has made retrospective adjustments to its financial statements for the previous year due to the implementation of new accounting standards regarding quality assurance [2] - Quality assurance fees previously recorded under sales expenses have been reclassified to operating costs, aligning with the new accounting treatment [2] Operational Improvements - The company has implemented measures to enhance management efficiency, reduce costs, and improve gross margins, leading to a positive impact on profit growth [2] - There has been a notable increase in net cash flow from operating activities compared to the previous year, contributing to the overall profit increase [2]

[Current Period Performance Forecast](index=1&type=section&id=Item%20I.%20Current%20Period%20Performance%20Forecast) The company anticipates substantial growth in H1 2025, with net profit attributable to shareholders increasing by 130-180% and operating revenue by 5-15% Key Performance Indicators for H1 2025 Performance Forecast | Item | Current Reporting Period (Jan 1 - Jun 30, 2025) | Prior Year Same Period | | :--- | :--- | :--- | | **Operating Revenue** | 414.36 million CNY - 453.82 million CNY | 394.63 million CNY | | Year-on-Year Growth | 5% - 15% | - | | **Net Profit Attributable to Shareholders** | Profit: 26.49 million CNY - 32.25 million CNY | Profit: 11.52 million CNY | | Year-on-Year Growth | 130% - 180% | - | | **Net Profit After Non-Recurring Gains/Losses** | Profit: 20.21 million CNY - 22.66 million CNY | Profit: 6.12 million CNY | | Year-on-Year Growth | 230% - 270% | - | | **Basic Earnings Per Share** | Profit: 0.09 CNY/share - 0.05 CNY/share | Profit: 0.03 CNY/share | - The company retrospectively adjusted the accounting treatment for guarantee-type quality assurance in accordance with 'Interpretation No. 18 of Accounting Standards for Business Enterprises' issued by the Ministry of Finance, reclassifying quality assurance expenses originally recorded under 'Selling Expenses' to 'Operating Costs', and made corresponding adjustments to the 2024 comparable financial statements[3](index=3&type=chunk)[4](index=4&type=chunk) [Communication with Accounting Firm](index=1&type=section&id=Item%20II.%20Communication%20with%20Accounting%20Firm) This performance forecast represents a preliminary estimate by the company's finance department and has not yet been audited - This performance forecast is a preliminary estimate by the company's finance department and has not been audited by an accounting firm[5](index=5&type=chunk) [Explanation of Performance Changes](index=2&type=section&id=Item%20III.%20Explanation%20of%20Performance%20Changes) H1 2025 performance growth is driven by successful project implementation and improved cost efficiency from refined management, with continued focus on core business and R&D in AI and data elements planned for H2 - Key reasons for H1 performance growth include: strengthened project progress control and implementation acceptance, leading to year-on-year operating revenue growth; and initial success of refined management and cost reduction initiatives since 2024, resulting in continuous improvement in project implementation costs and gross margins[6](index=6&type=chunk) - The company plans to continue focusing on its core business in H2 2025, increasing R&D and innovation investment in products related to artificial intelligence, data elements, and blockchain, to promote high-quality sustainable development[6](index=6&type=chunk) [Risk Warning](index=2&type=section&id=Item%20IV.%20Risk%20Warning) Investors are cautioned that the financial data in this forecast are preliminary, with final details to be disclosed in the 2025 semi-annual report - The company advises that specific H1 2025 financial data will be detailed in the official semi-annual report, and investors are urged to be aware of investment risks[7](index=7&type=chunk)

Group 1 - The company, Jiuyuan Yinhai (002777), announced an expected net profit attributable to shareholders ranging from 26.49 million to 32.25 million yuan for the period from January 1, 2025, to June 30, 2025, representing a growth of 130% to 180% compared to the same period last year, which recorded a net profit of 11.52 million yuan [1]

Core Insights - Chengdu's "免申即享" (No Application, Immediate Enjoyment) policy is effectively streamlining the process for companies to receive financial support without the need for extensive applications, enhancing the business environment [1][4][5] Group 1: Impact on Companies - The "免申即享" funding has provided immediate financial relief to companies like Shuyun Tianfu Panda Creative Cultural Tourism Co., which has alleviated cash flow pressures and boosted long-term confidence in project development [3][4] - Sichuan Jiuyuan Yinhai Software Co. has also benefited from the policy, receiving funds without the previous burdens of application processes, which has improved operational efficiency and innovation confidence [3][4] - The policy has transformed the traditional approach of "companies seeking policies" to "policies seeking companies," significantly reducing the time and effort required for funding applications [4][5] Group 2: Government Initiatives - Chengdu's government has established a mechanism to prioritize the "免申即享" approach in new policy formulations, with a current implementation rate of 30% for new business support policies [5][6] - The city has committed to enhancing the feasibility assessment of the "免申即享" approach in new policies, ensuring that a higher percentage of support measures are accessible without cumbersome application processes [5][6] - Ongoing reforms aim to further increase the proportion of "免申即享" policies, improving the overall experience and satisfaction of businesses with government support [6]

Core Viewpoint - The digital hospital industry in China is experiencing rapid growth, with the market size expected to reach 487.7 billion yuan in 2024 and 525 billion yuan in 2025, driven by advancements in technology and the need for modernization in healthcare [1][4][6]. Digital Hospital Industry Definition and Classification - Digital hospitals utilize advanced computer network systems to integrate patient diagnosis, health economic information, and hospital management data into a comprehensive information management system [2][4]. - Key products in the digital hospital industry include Hospital Information Systems (HIS), Clinical Information Systems (CIS), Picture Archiving and Communication Systems (PACS), Laboratory Information Systems (LIS), and Electronic Medical Records (EMR) [2]. Current Development Status of the Digital Hospital Industry - The digital hospital market in China has grown from 18.2 billion yuan in 2014 to 487.7 billion yuan in 2024, with projections for 2025 indicating further growth [4][6]. - The digital transformation of hospitals is essential for adapting to societal changes and improving operational efficiency [4][6]. Industry Structure and Value Chain - The digital hospital industry value chain includes upstream technology and equipment suppliers, midstream solution integrators, and downstream hospitals [8]. - The application of digital solutions in hospitals is expanding, enhancing operational efficiency and service delivery [8]. Development Environment and Relevant Policies - The Chinese government has implemented various policies to support the digital transformation of hospitals, emphasizing the need for electronic medical records and health information sharing [10][12]. - Key policies include the promotion of smart hospitals and the integration of health information systems across regions [10][12]. Competitive Landscape of the Digital Hospital Industry - The market features both domestic and international players, with major companies including Microsoft, Cisco, IBM, and domestic firms like Eastsoft, Founder, Huawei, and others [13][15]. - Domestic companies are increasingly gaining market share, focusing on providing comprehensive digital solutions for hospitals [13][15]. Key Companies in the Digital Hospital Industry - Eastsoft has over 300 proprietary products and provides comprehensive information solutions for hospitals, with projected revenues of 13.32 billion yuan in 2024 [15]. - Chuangyue Huikang has implemented over 10,000 healthcare information projects and serves more than 7,000 clients, with revenues of 1.423 billion yuan in 2024 [17]. Implementation Pathways for Digital Transformation - The digital transformation of hospitals requires top-level design, scientific data management, and strengthening of academic disciplines to enhance information management capabilities [19][21][22]. - Emphasis on cross-disciplinary collaboration and talent development is crucial for achieving sustainable growth in hospital information management [22][23].

证券代码：002777 证券简称：久远银海 公告编号：2025-025 四川久远银海软件股份有限公司 关于全资子公司完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 注册资本：伍仟万元整 成立日期：2014 年 04 月 24 日 经营范围：计算机系统软件、硬件系统、网络设备、监控设备、办公用品的销售及技术 服务；计算机软、硬件的开发、销售、技术服务及技术咨询；弱电工程设计与施工。（以上 经营范围，需许可、备案的取得许可、备案后经营，需资质的凭资质经营）（依法须经批准 的项目，经相关部门批准后方可开展经营活动）。 二、备查文件 一、基本情况 四川久远银海软件股份有限公司（以下简称"公司"）全资子公司四川久远银海畅辉软 件有限公司（以下简称"银海畅辉公司"）因经营需要，于近日完成了法定代表人变更的工 商登记手续，并取得了绵阳市涪城区政务服务和行政审批局核准换发的《营业执照》，本次 工商登记变更除法定代表人变更外，其他登记事项未发生变更。变更后的营业执照基本信息 如下： 公司名称：四川久远银海畅辉软件有限公司 统一社会信用代码： ...

Core Viewpoint - Sichuan Jiuyuan Yinhai Software Co., Ltd. has been recognized as a "2024 Sichuan ESG Benchmark Enterprise," highlighting its commitment to environmental, social, and governance (ESG) practices in its operations [3][4]. Group 1: ESG Commitment - The company has made significant investments in green development, social responsibility, and governance practices, which have been acknowledged through the ESG award [3]. - Jiuyuan Yinhai focuses on three main areas: healthcare insurance, digital government, and smart cities, serving over 700 million people across 29 provinces and 240+ cities [3][4]. Group 2: Environmental Responsibility - The company has implemented measures to promote energy conservation and resource utilization, achieving a reduction in carbon emissions by 66,552.17 kg in 2024, representing a 5.71% savings rate [4]. - Initiatives include promoting low-carbon office practices, encouraging healthy low-carbon diets, and creating a comfortable working environment [4]. Group 3: Social Responsibility - Jiuyuan Yinhai has contributed significantly to public welfare through its work in healthcare and digital governance, supporting the operation of national healthcare information platforms across 23 provinces [4]. - The company has won six awards at the "2024 National Smart Healthcare Competition," becoming the most awarded entity, and has developed various social security systems benefiting over ten million users [4]. Group 4: Governance Improvement - In 2024, the company has enhanced its governance level by introducing new policies and revising management methods to strengthen execution and control over critical processes [5]. - Jiuyuan Yinhai has maintained a AAA credit rating in the software service industry for 14 consecutive years, reflecting its operational excellence and governance standards [5].

Group 1 - Fengcai Technology is conducting an H-share issuance with a maximum price of 120.50 HKD per share, aiming to raise funds for its specialized chip business [1] - The global offering consists of 16.3 million shares, with 1.63 million shares available for public offering in Hong Kong [1] - Zijin Mining plans to acquire the Raygorodok gold mine project in Kazakhstan for 1.2 billion USD, enhancing its resource portfolio [1][2] Group 2 - Mindray Medical's shareholder plans to reduce holdings by up to 5 million shares, approximately 0.41% of the total share capital, due to personal funding needs [3] - Degute is planning to acquire control of Haowei Technology through a combination of cash and share issuance, leading to a temporary suspension of its stock [4] - New Dairy's controlling shareholder intends to reduce its stake by up to 3% of the total share capital, also for funding purposes [5] Group 3 - Yueyang Xinchang has resumed production after completing maintenance on its main production facilities, positively impacting its operations [6] - Chengdu Xian Dao has terminated its major asset restructuring plan due to failure to reach agreement on key terms [7] - Maglev Technology's shareholder plans to reduce its stake by up to 3% of the total share capital for personal financial arrangements [9] Group 4 - Zhongyan Dadi announced a cash dividend of 2.82 CNY per 10 shares and a capital increase of 3.99 shares per 10 shares [10] - Yunda Co. plans to distribute a cash dividend of 0.6 CNY per 10 shares, totaling approximately 47.22 million CNY [12] - Victory Co. intends to distribute a cash dividend of 0.42 CNY per 10 shares, amounting to around 36.06 million CNY [13] Group 5 - Shagang Group has invested 2.67 billion CNY in financial products while planning to use up to 8 billion CNY of idle funds for further investments [14] - Jiuyuan Yinhai's subsidiary won an 8.43 million CNY project contract, constituting a related party transaction [15] - China Railway Signal & Communication has announced the resignation of a board member due to personal reasons [16] Group 6 - China Rare Earth clarified that recent management changes have not affected its operations, ensuring stability in production [17] - Qixiang Tengda plans to conduct routine maintenance on its 60,000-ton acetone plant for 60 days to enhance operational safety [19] - ST King Kong's subsidiary signed a 399 million CNY contract for computing power services, indicating growth in its service offerings [20] Group 7 - Ziguang Guowei repurchased 775,500 shares for approximately 49.62 million CNY, reflecting confidence in its market position [22] - Qin Port's major shareholder plans to reduce its stake by up to 2% of the total share capital for development needs [22] - Longqi Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, expanding its market presence [24]

Group 1 - The board meeting of Sichuan Jiuyuan Yinhai Software Co., Ltd. was held on June 27, 2025, via communication method, with all 9 directors participating in the voting [1] - The board approved a proposal related to a connected transaction, with a voting result of 7 votes in favor, 0 against, 0 abstentions, and 2 abstentions due to conflict of interest [1] - The independent directors had previously reviewed the proposal in a dedicated meeting, with a voting result of 5 votes in favor, 0 against, 0 abstentions, and 4 abstentions due to conflict of interest [2] Group 2 - The announcement regarding the connected transaction will be disclosed in various financial newspapers and on the official website [1] - The board meeting adhered to relevant laws, regulations, and the company's articles of association [1] - The company ensures that the information disclosed is true, accurate, and complete, with no false records or significant omissions [1]

Group 1 - The company, Sichuan Jiuyuan Yinhai Software Co., Ltd., is set to enter into a procurement contract with a subsidiary of the China Engineering Physics Research Institute, with a total contract value of approximately 8.43 million yuan [1][3] - The China Engineering Physics Research Institute, established in 1958, is a key national military research institute focused on advanced defense science and technology [2] - The procurement contract was determined through a competitive negotiation process, ensuring fair pricing and compliance with market principles [3][4] Group 2 - The company has reported a total of 1.644 million yuan in various related transactions with the same related party from the beginning of the year to the disclosure date [3] - Independent directors have reviewed the related transaction and unanimously agreed that it aligns with the company's operational situation and does not harm the interests of shareholders [4]